Recreational Cannabis Legalization Tied to Higher Prenatal Use
By Lori Solomon HealthDay Reporter
TUESDAY, Nov. 5, 2024 -- The implementation of recreational cannabis legalization (RCL) in California was associated with an increase in prenatal cannabis use, according to a study published online Nov. 1 in JAMA Health Forum.
Kelly C. Young-Wolff, Ph.D., from Kaiser Permanente Northern California in Pleasanton, and colleagues assessed whether RCL in California was associated with changes in prenatal cannabis use rates detected via both self-report and urine toxicology testing. The analysis included universal screening results for cannabis use during early pregnancy from 300,993 pregnancies (236,327 unique individuals) from 2012 through 2019.
The researchers found that before RCL implementation, rates of prenatal cannabis use rose steadily from 4.5 percent in January 2012 to 7.1 percent in January 2018. At the time of RCL passage (Nov. 9, 2016), there was no change in use rates (level change rate ratio [RR], 1.03; 95 percent confidence interval [CI], 0.96 to 1.11). However, there was a statistically significant increase in rates in the first month after RCL implementation (January 2018), increasing to 8.6 percent in February 2018 (level change RR, 1.10). Similar results were seen for prenatal cannabis use detected via toxicology test or self-report. The post-RCL implementation increase in use was only seen in jurisdictions allowing adult-use cannabis retailers (allowed: RR, 1.21 [95 percent CI, 1.10 to 1.33]; banned: RR, 1.01 [95 percent CI, 0.93 to 1.10]).
"Clinicians can provide education to all patients during the preconception and prenatal periods about the potential risks associated with prenatal cannabis use so that patients can make well-informed decisions," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-06 06:00
Read more
- Change in Alzheimer's Drug Vial Size Could Be Big Money-Saver for Medicare
- U.S. Scientists Awarded Nobel Prize in Medicine for Groundbreaking DNA Discovery
- Geographic Position Influences Climate Change Risk Perception of Emergency Medical Services
- When Complications Strike After Heart Surgery, Women More Likely to Die Than Men
- FDA Approves Hympavzi (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors
- Semaglutide Beneficial for People With Obesity, Knee Osteoarthritis
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions